31 January 2022

Pulmonary hypertension community call - January 2022

In this call, our moderator Dr Jason Weatherald is joined by our three PVRI Social Champions, Charifa Awada, Sokratis Kariotis and Tatiana Kudryashova to discuss the latest developments in PH this month. Topics include:

  • Imatinib vs Dasatinib
  • Tyrosine kinase inhibitors in PAH and the double edge swords between inhibiting or inducing PAH
  • Can today's data be efficiently used as an input for machine learning?
  • Biological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood

Articles featured in this call

  • https://erj.ersjournals.com/content/57/5/2003271
  • https://www.nature.com/articles/s41467-021-27326-0

Comments (0)

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI